A randomized controlled study to examine the effects of a triple therapy with vonoprazan or rabeprazole against standard triple therapy-failed patients.
Not Applicable
- Conditions
- Helicobacter pylori infection
- Registration Number
- JPRN-UMIN000016601
- Lead Sponsor
- Juntendo University School of Medicine, Department of Gstroenterology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who cannot cancel a proton pump inhibitor for 2 weeks before judgment after re-eradication therapy. 2. Patients who have past history of drug allergy. 3. Patients who have severe diseases affecting the kidney, the heart, and the liver. 4. Patients who are pregnant, who may be pregnant, or who are nursing.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison on an eradication rate between a triple therapy with vonoprazan and a triple therapy with rabeprazole
- Secondary Outcome Measures
Name Time Method Comparison of adverse effects between a triple therapy with vonoprazan and a triple therapy with rabeprazole